Form 4: Doximity Director Reports Planned Stock Sale
Insider Transaction Report
Doximity Director Kira Wampler reported the exercise of stock options and subsequent sale of Class A Common Stock totaling 2,000 shares, executed under a Rule 10b5-1 trading plan.
Summary
- Kira Wampler, a Director of Doximity, Inc., reported transactions involving the company's stock.
- On October 1, 2025, Wampler converted 2,000 shares of Class B Common Stock into Class A Common Stock.
- Concurrently, 2,000 shares of Class A Common Stock were sold at a price of $70.01 per share.
- These transactions were executed automatically pursuant to a Rule 10b5-1 trading plan adopted on November 12, 2024.
- Following these transactions, Wampler beneficially owns 19,839 shares of Class A Common Stock and 466,700 shares of Class B Common Stock.
- The Class B Common Stock is convertible into Class A Common Stock on a one-for-one basis at the holder's option or automatically under certain conditions.
Sentiment
Score: 5
Explanation: The filing reports routine insider transactions under a pre-planned Rule 10b5-1 trading plan, which is generally neutral in sentiment. While a sale reduces insider ownership, the pre-planned nature mitigates negative implications.
Positives
- The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned and not reactive sale.
- The exercise of stock options indicates the realization of value from previously granted equity incentives.
Negatives
- A director's sale of shares, even if pre-planned, can sometimes be perceived negatively by the market as it reduces insider ownership.
Risks
- Potential negative market perception if investors misinterpret the planned sale as a lack of confidence, despite the Rule 10b5-1 plan.
Future Outlook
NA
Industry Context
NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Grant | Kira Wampler granted a Limited Power of Attorney to Anna Bryson and John Vaughan to execute and file SEC forms (Form ID, 3, 4, 5, Schedules 13D/G) on her behalf. | September 3, 2025 | Standard practice for Section 16 reporting persons to streamline compliance with SEC filing requirements. |
Stakeholder Impact
- Shareholders: Minor potential for negative perception due to insider selling, though mitigated by the Rule 10b5-1 plan.
Next Steps
- Continued execution of the Rule 10b5-1 trading plan as per its terms.
Key Dates
| Date | Description |
|---|---|
| March 27, 2020 | Start of stock option vesting period. |
| June 10, 2020 | Stock option grant date. |
| November 12, 2024 | Date Rule 10b5-1 trading plan was adopted by Reporting Person. |
| September 3, 2025 | Date Limited Power of Attorney was executed by Kira Wampler. |
| October 1, 2025 | Date of reported stock conversion and sale transactions. |
| June 9, 2030 | Expiration date of stock option. |
Keywords
Doximity, DOCS, Kira Wampler, Form 4, insider trading, stock sale, Rule 10b5-1, director, equity conversion, stock options
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.